Call for targeted EU research into heart disease sciencebusiness.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencebusiness.net Daily Mail and Mail on Sunday newspapers.
Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
21/04/2021 - 5 minutes
Last month’s EU approval of Vazkepa a treatment derived from fish oil and branded as Vascepa in the US has added much-needed ammunition to the arsenal of doctors battling cardiovascular disease. Yet other similar treatments are returning lukewarm results and the possibility of approvals being withdrawn hangs in the air.
Icosapent ethyl, a derivative of fish oil formulated by US-Irish biotech Amarin, recently became the first approved treatment in the EU to reduce the risk of strokes and heart attacks in patients with elevated triglycerides a type of fat who have previously been treated with statins.